Omnicare settles kickback, FCA cases for $31 million
By
Jul 06, 2017
Long-term care pharmacy giant Omnicare agreed to pay a total of $31 million in May to settle allegations it submitted false claims and accepted kickbacks to promote certain drugs.
Change Healthcare touts attachment capability
By
Kimberly Marselas
Jan 21, 2020
Change Healthcare has beefed up its claim attachments solution, creating the first nationwide solution enabling providers to submit documents and data electronically to all payers in both the medical and...
CMS issues notice of sanctions to Medicare Advantage insurer
May 19, 2010
The Centers for Medicare & Medicaid Services this week informed Medicare Advantage insurer Quality Health Plans of its intent to impose intermediate sanctions and a civil monetary penalty (CMP) on the...
UTI discovery could trigger new treatment
By
Julie Williamson
Aug 14, 2019
mproved treatment for recurring urinary tract infections could be on the horizon thanks to new research findings from a University of Queensland and University of Utah study.
Common painkiller may help reverse Alzheimer’s-related memory loss
By
Aug 15, 2016
An anti-inflammatory drug commonly used to treat pain associated from menstrual cramps may be able to reverse memory loss linked to Alzheimer’s disease, new research shows.
New guidance for treating hypoglycemia in long-term care stresses understanding of glucagon
By
Kristen Fischer
Aug 21, 2023
There’s some new guidance on treating hypoglycemia, or low blood sugar, in long-term care communities. It’s specifically geared for healthcare workers, though anyone who is a caregiver for someone...
Genes influence likelihood of hip fractures among older adults
By
Haymarket Media
Sep 30, 2005
Heredity plays a role in determining whether people under 69 will suffer a first hip fracture, a new study says.
B12 believed to help ward off Alzheimer’s
By
Haymarket Media
Apr 16, 2004
Researchers believe that seniors who include B12 and folate supplements in their daily routines may be at lower risk of getting Alzheimer’s disease.
Researchers spot whose cognitive ability may shift during dementia trials
By
Kristen Fischer
Jan 17, 2024
People who changed cognitive status from impaired to normal during clinical trials tend to be younger, have better cognition and be negative for amyloid biomarkers, according to a new study.
Clinical briefs for Wednesday, July 28
By
Alicia Lasek
Jul 28, 2021
Vaccine reporting requirements overwhelm providers during COVID-19 outbreaks … Delta variant’s spread prompts CDC to re-up indoor mask-wearing recommendation … VA becomes first federal department...